Press "Enter" to skip to content

New patent for Otsuka America drug SAMSCA

2
Copyright © DrugPatentWatch. Originally published at New patent for Otsuka America drug SAMSCA

Annual Drug Patent Expirations for SAMSCA
Annual Drug Patent Expirations for SAMSCA

Samsca is a drug marketed by Otsuka America Pharm and is included in one NDA. It is available from two suppliers. There are two patents protecting this drug and two Paragraph IV challenges.

Drug patent litigation for SAMSCA.

This drug has sixty-four patent family members in nineteen countries.

The generic ingredient in SAMSCA is tolvaptan. Two suppliers are listed for this compound. Additional details are available on the tolvaptan profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Otsuka America drug SAMSCA

Comments are closed.

Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions